Optos Announces Largest U.S. Reference Database for Ultra-widefield and OCT Imaging
“With the largest reference database of its kind in the U.S., Optos continues to set the standard for precision and innovation in ophthalmic imaging,” said Optos Chief Executive Officer Robert Kennedy. “Our commitment to advancing clinical tools empowers eyecare professionals with high-quality data, ensuring greater confidence in patient assessments and improving early disease detection.”
Key Database Highlights
Largest U.S.-Cleared Reference Database
The Optos RDB includes the highest number of patients of any cleared U.S. database. It comprises 879 eyes, aged 22-84, collected across nine clinical sites, offering a diverse and representative dataset to support clinical evaluations.
Exclusive to Monaco and MonacoPro
The database is integrated into the Monaco and MonacoPro platforms, providing essential guidance for assessing retinal thickness, ganglion cell complex (GCC) thickness, and optic nerve head (ONH) metrics. This integration supports the detection of abnormalities associated with conditions such as diabetic macular edema (DME) and glaucoma.
Industry-Leading Commitment to Innovation
As reference databases become more ubiquitous, Optos' approach remains focused on maintaining the most extensive and clinically relevant dataset, ensuring that eyecare professionals have access to the best tools for accurate patient evaluation.
Optos remains dedicated to delivering groundbreaking solutions in ocular imaging, reinforcing its position as a global leader in ultra-widefield and OCT technology. The introduction of this RDB further demonstrates Optos' unwavering commitment to clinical excellence and innovation in eye care.
For more information about Optos and our industry-leading retinal imaging technology, please visit www.optos.com.
About Optos
For more than 30 years, Optos has been the exclusive provider of 200-degree single-shot ultra-widefield retinal imaging systems to eye care professionals worldwide. With over 27,000 devices in use and supported by more than 3,000 clinical papers,
Optos has also developed integrated ultra-widefield retinal imaging with optomap-guided Optical Coherence Tomography (OCT). Optos devices facilitate the early detection, management, and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. Optos continues to lead the way in retinal imaging technology, setting the standard for excellence and innovation in eye care.
Media Contact:
Cassy Dump
Shine Communications for Optos
(619) 971-1887
Organization Contact:
Sharon Shepard